B
Bryan Burmeister
Researcher at Princess Alexandra Hospital
Publications - 163
Citations - 8693
Bryan Burmeister is an academic researcher from Princess Alexandra Hospital. The author has contributed to research in topics: Radiation therapy & Chemoradiotherapy. The author has an hindex of 39, co-authored 158 publications receiving 7908 citations. Previous affiliations of Bryan Burmeister include Sir Charles Gairdner Hospital & University of Queensland.
Papers
More filters
Journal ArticleDOI
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
Katrin Marie Sjoquist,Bryan Burmeister,B. Mark Smithers,B. Mark Smithers,John Zalcberg,R. John Simes,Andrew Barbour,Andrew Barbour,Val Gebski +8 more
TL;DR: This updated meta-analysis provides strong evidence for a survival benefit of neoadjuvant chemoradiotherapy or chemotherapy over surgery alone in patients with oesophageal carcinoma and investigates treatment effects by tumour histology and relations between risk (survival after surgery alone) and effect size.
Journal ArticleDOI
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis
TL;DR: A significant survival benefit was evident for preoperative chemoradiotherapy and, to a lesser extent, for chemotherapy in patients with adenocarcinoma of the oesophagus and the findings provide an evidence-based framework for the use of neoadjuvant treatment in management decisions.
Journal ArticleDOI
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.
Bryan Burmeister,B. Mark Smithers,Val Gebski,Lara Fitzgerald,R. John Simes,Peter G. Devitt,Stephen P. Ackland,David C. Gotley,David Joseph,Jeremy Millar,John B. North,Euan Walpole,James W. Denham +12 more
TL;DR: Preoperative chemoradiotherapy with cisplatin and fluorouracil does not significantly improve progression-free or overall survival for patients with resectable oesophageal cancer compared with surgery alone, and further assessment is warranted of the role of cheMoradiotherapy in patients with squamous-cell tumours.
Journal ArticleDOI
Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04
Samuel Y Ngan,Bryan Burmeister,Richard Fisher,Michael J. Solomon,David Goldstein,David Joseph,Stephen P. Ackland,David Schache,B. McClure,Sue-Anne McLachlan,Joseph McKendrick,Trevor Leong,Cris Hartopeanu,John Zalcberg,John Mackay +14 more
TL;DR: Three-year LR rates between SC and LC were not statistically significantly different; the CI for the difference is consistent with either no clinically important difference or differences in favor of LC, which may be more effective in reducing LR for distal tumors.
Journal ArticleDOI
Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial
Bryan Burmeister,Janine Thomas,Elizabeth Burmeister,Euan Walpole,Jennifer Harvey,Damien Thomson,Andrew Barbour,Andrew Barbour,David C. Gotley,David C. Gotley,B. Mark Smithers,B. Mark Smithers +11 more
TL;DR: Despite no difference in survival, the improvement from preoperative CRT with respect to margin involvement makes this treatment a reasonable option for bulky, locally advanced resectable adenocarcinoma of the oesophagus.